If approved, Awiqli would become the first once-weekly basal insulin available in the United States for adults with Type 2 ...

By Shreoshree Chakrabarty: For individuals managing diabetes, insulin must be administered into the subcutaneous tissue—the layer of fat located between the skin and muscle. This tissue, also called ...

Novo Nordisk today announced the resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Awiqli® (insulin icodec) injection, a once-weekly basal ...

A technical advance in search of its clinical place Insulin remains a cornerstone of treatment for many people with type 2 diabetes whose blood glucose levels are not adequately controlled with oral ...

Toujeo is an injectable insulin medication for the treatment of diabetes (type 1 or type 2) in people who are 6 years old and older. It is a long-acting form of insulin, which allows it to last for a ...